Matt Birnholz, MD
Marina Magrey, MD
Quality of Life in Patients with PsA: Disease Domain Impacts
Jennifer Caudle, DO
Siba Raychaudhuri, MD
The Role of IL-17 in PsA Pathophysiology and Treatment Plans
Comprehending the PsA Agents in Late-Stage Clinical Development
William D. Tap, MD
Silvia Stacchiotti, MD
Michiel van de Sande, MD, PhD
Andrew J. Wagner, MD, PhD
Improving Clinical Practices in the Management of Tenosynovial Giant Cell Tum...
Tenosynovial Giant Cell Tumor (TGCT): New Perspectives on Advances in Treatment
Leonard H. Calabrese, DO
John R. Tesser, MD
Pinpointing the Top Questions about Biosimilars in Rheumatology
Stay current with the best on medical education
We’re glad to see you’re enjoying Rheumatology Academy…but how about a more personalized experience?
Press cancel to remain on Rheumatology Academy. Press the link below or the continue button to keep going.